期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 60, 期 4, 页码 2402-2416出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.02776-15
关键词
-
资金
- Ministerio de Economia y Competitividad (MINECO) \ Instituto de Salud Carlos III (ISCIII) [PI10/00512, PI10/01734]
- Ministerio de Economia y Competitividad (MINECO) [BFU2011-24112, BFU2014-58656R]
- Generalitat Valenciana (Regional Government of Valencia) [FPA/2013/A/083, ACOMP/2013/086]
- Ministerio de Educacion, Cultura y Deporte (MECD) [FPU-AP2010-0561]
There is no comprehensive study available on the natural hepatitis C virus (HCV) polymorphism in sites associated with resistance including all viral genotypes which may present variable susceptibilities to particular direct-acting antivirals (DAAs). This study aimed to analyze the frequencies, genetic barriers, and evolutionary histories of naturally occurring resistance-associated variants (RAVs) in the six main HCV genotypes. A comprehensive analysis of up to 103 RAVs was performed in 2,901, 2,216, and 1,344 HCV isolates for the NS3, NS5A, and NS5B genes, respectively. We report significant intergenotypic differences in the frequencies of natural RAVs for these three HCV genes. In addition, we found a low genetic barrier for the generation of new RAVs, irrespective of the viral genotype. Furthermore, in 1,126 HCV genomes, including sequences spanning the three genes, haplotype analysis revealed a remarkably high frequency of viruses carrying more than one natural RAV to DAAs (53% of HCV-1a, 28.5% of HCV-1b, 67.1% of HCV-6, and 100% of genotype 2, 3, 4, and 5 haplotypes). With the exception of HCV-1a, the most prevalent haplotypes showed RAVs in at least two different viral genes. Finally, evolutionary analyses revealed that, while most natural RAVs appeared recently, others have been efficiently transmitted over time and cluster in well-supported clades. In summary, and despite the observed high efficacy of DAA-based regimens, we show that naturally occurring RAVs are common in all HCV genotypes and that there is an overall low genetic barrier for the selection of resistance mutations. There is a need for natural DAA resistance profiling specific for each HCV genotype.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据